Use of Angiotensin‐Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Is Associated With a Reduced Risk of Poststroke Epilepsy in Patients With Ischemic Stroke

Key Points

Key points are not available for this paper at this time.

Abstract

Poststroke epilepsy (PSE) is a common complication after ischemic stroke. This study investigates the association between the use of angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) and the risk of PSE in patients with ischemic stroke.

Read Full Paperexternally

Bookmark

View Full Paper

Cite This Study

Chang et al. (Tue,) studied this question.

synapsesocial.com/papers/68e5ab88b6db643587545140 https://doi.org/https://doi.org/10.1161/jaha.124.035438

Bookmark

View Full Paper